Evans syndrome is a serious autoimmune condition in which a dog’s immune system destroys both its red blood cells and its platelets at the same time. It combines two separate immune disorders: immune-mediated hemolytic anemia (IMHA), where the body attacks red blood cells, and immune-mediated thrombocytopenia (ITP), where it attacks platelets. This double assault makes Evans syndrome more dangerous than either condition alone, and it carries a particularly high mortality rate compared to IMHA or ITP occurring individually. Roughly 30% of dogs diagnosed with IMHA also have concurrent platelet destruction, qualifying them for an Evans syndrome diagnosis.
How the Immune System Turns on Itself
In a healthy dog, the immune system produces antibodies that target foreign invaders like bacteria and viruses. In Evans syndrome, something goes wrong and the immune system begins producing antibodies that latch onto the surface of the dog’s own red blood cells and platelets, marking them for destruction. This is classified as a type II immune reaction, where antibody attachment triggers a chain of events that breaks down these blood cells.
Red blood cells carry oxygen throughout the body, so their destruction causes anemia. Platelets are responsible for clotting, so their loss means the blood can’t seal wounds or prevent internal bleeding. When both are under attack simultaneously, the dog faces oxygen deprivation and uncontrolled bleeding at the same time. The underlying trigger for this immune malfunction is often unknown, though infections, certain medications, vaccines, and cancer can sometimes set it off.
Signs to Watch For
The symptoms of Evans syndrome reflect both the anemia and the platelet loss. Dogs typically become lethargic and weak because their tissues aren’t getting enough oxygen. Their gums and inner eyelids may look pale or even yellowish (jaundiced) as destroyed red blood cells release pigments into the bloodstream.
The platelet side of the disease shows up as unusual bleeding. You may notice tiny red or purple dots on your dog’s gums, belly, or inner ears. These are called petechiae, and they’re pinpoint hemorrhages caused by critically low platelet counts. Larger bruises (ecchymoses) can appear on the abdomen or other areas with thin skin. Some dogs develop dark, tarry stools from bleeding in the digestive tract, or blood in their urine.
A racing heart is common because the body compensates for fewer red blood cells by pumping blood faster. A heart murmur may appear in dogs that didn’t have one before, simply because the blood is thinner and flows more turbulently. Fever is also possible. In one documented case, a dog with Evans syndrome presented with a heart rate of 150 beats per minute, pale gums covered in petechiae, abdominal bruising, and evidence of intestinal bleeding.
How Veterinarians Diagnose It
Diagnosing Evans syndrome requires confirming that both the anemia and the low platelet count are immune-mediated, meaning the immune system is the cause rather than infection, toxin exposure, or cancer.
A complete blood count is the starting point. It reveals the severity of the anemia and shows how low the platelet count has dropped. Spontaneous bleeding becomes a risk when platelet numbers fall below about 30,000 to 50,000 per microliter, though the actual bleeding can be unpredictable.
One key test is the slide agglutination test, where a drop of the dog’s blood is mixed with saline on a glass slide. If the red blood cells clump together visibly, it suggests antibodies are coating their surface and causing them to stick. However, this clumping only happens when antibody levels are high, so a negative result doesn’t rule out the disease.
If the slide test is inconclusive, a direct Coombs’ test (also called a direct antiglobulin test) can detect antibodies or immune proteins stuck to red blood cells even when they aren’t causing visible clumping. This test catches more cases, but its sensitivity ranges from about 60% to 89%, meaning some dogs with immune-mediated destruction will still test negative. Veterinarians often rely on the overall clinical picture, ruling out other causes of anemia and low platelets like tick-borne infections, bone marrow disease, or cancer before settling on Evans syndrome as the diagnosis.
Treatment and What to Expect
Treatment centers on suppressing the immune system so it stops destroying blood cells. Corticosteroids are the first-line therapy and remain the cornerstone of treatment. The goal is to slow down the immune attack quickly enough that the body can begin replacing its lost red blood cells and platelets.
Many dogs with Evans syndrome need more aggressive treatment than a single immunosuppressive drug can provide. If corticosteroids alone aren’t enough, or if the case is severe from the start, veterinarians add a second immunosuppressive medication. Options include cyclosporine, azathioprine, mycophenolate, or leflunomide, each working through a different mechanism to further quiet the immune response. In some cases, human intravenous immunoglobulin is used to help stabilize the dog during the initial crisis.
Blood transfusions are frequently necessary to keep the dog alive while the medications take effect. Transfused red blood cells buy time, but they’re also vulnerable to the same immune attack, so they don’t last as long as they normally would. The first several days of treatment are the most critical, and many dogs require hospitalization with close monitoring.
The Clotting Paradox
One of the trickiest aspects of Evans syndrome involves blood clots. About 50% of dogs with IMHA are in a hypercoagulable state at the time of diagnosis, meaning their blood is prone to forming dangerous clots, particularly in the lungs. Anti-clotting medication is standard in IMHA treatment. But in Evans syndrome, the severe platelet loss already makes the dog unable to clot normally. Using anti-clotting drugs in this situation could worsen bleeding. This balancing act between clotting risk and bleeding risk is one reason Evans syndrome is so difficult to manage.
Pulmonary thromboembolism, a blood clot in the lungs, is one of the most common causes of sudden death in dogs with IMHA. If a dog develops sudden, severe difficulty breathing during treatment, this is the likely culprit.
Survival Rates and Prognosis
Evans syndrome carries a higher mortality rate than IMHA alone, which itself is already a serious disease. Studies on IMHA report mortality rates ranging widely from 20% to 80% depending on the study population and treatment approach. One University of Wisconsin study of 72 dogs with IMHA found a 58% mortality rate. A larger Cornell University study of 151 dogs reported better outcomes, with 76% surviving, 9% dying during treatment, and 15% being euthanized. Evans syndrome cases generally fall toward the worse end of these ranges because the dual immune attack creates more complications and limits treatment options.
Dogs that survive the initial crisis still face a long recovery. Immunosuppressive medications are tapered gradually over weeks to months, and stopping them too quickly can trigger a relapse. Regular blood work is essential throughout the tapering process to catch any early signs that the immune system is ramping up again. Relapses are common with immune-mediated blood diseases, and some dogs require low-dose immunosuppressive therapy for life.
Which Dogs Are at Risk
Evans syndrome can strike any breed, but the underlying conditions that comprise it, IMHA and ITP, are more common in certain breeds. Cocker Spaniels, Springer Spaniels, Poodles, Old English Sheepdogs, and Irish Setters appear more frequently in IMHA studies. Middle-aged dogs are most commonly affected, and females may be at slightly higher risk than males. That said, the condition can appear in any dog at any age, and many cases arise with no identifiable trigger or breed predisposition.
Living With Evans Syndrome
If your dog is diagnosed with Evans syndrome and survives the acute phase, long-term management becomes a routine part of life. You’ll need periodic blood draws to monitor red blood cell levels and platelet counts, especially during medication changes. Side effects from immunosuppressive drugs are common and can include increased thirst, increased urination, weight gain, panting, and susceptibility to infections. These side effects are generally manageable and improve as doses are reduced.
Watch for recurrence of the signs that first brought your dog in: lethargy, pale gums, unusual bruising, or dark stools. Catching a relapse early, before the blood counts drop to dangerous levels, dramatically improves the chances of getting it back under control. Some dogs go into long-term remission and eventually come off all medications. Others need ongoing low-dose treatment to keep their immune system in check.